Guardian Pharmacy Services (NYSE:GRDN) Insider Sells $19,928,101.76 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Fred Burke sold 671,432 shares of Guardian Pharmacy Services stock in a transaction on Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $19,928,101.76. Following the sale, the insider owned 840,413 shares in the company, valued at $24,943,457.84. The trade was a 44.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Guardian Pharmacy Services Price Performance

Shares of NYSE GRDN opened at $37.58 on Wednesday. The stock has a market capitalization of $2.38 billion, a PE ratio of 48.81 and a beta of 0.86. Guardian Pharmacy Services, Inc. has a one year low of $19.17 and a one year high of $38.12. The business’s fifty day moving average price is $32.49 and its 200-day moving average price is $29.83.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.10. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.The firm had revenue of $397.62 million during the quarter, compared to analyst estimates of $390.04 million. Guardian Pharmacy Services’s revenue was up 17.4% compared to the same quarter last year. As a group, equities analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several institutional investors and hedge funds have recently added to or reduced their stakes in GRDN. Dynamic Technology Lab Private Ltd bought a new stake in shares of Guardian Pharmacy Services during the 1st quarter valued at $233,000. Envestnet Asset Management Inc. grew its position in shares of Guardian Pharmacy Services by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock worth $258,000 after buying an additional 805 shares during the period. Geode Capital Management LLC increased its stake in shares of Guardian Pharmacy Services by 65.9% in the 2nd quarter. Geode Capital Management LLC now owns 336,701 shares of the company’s stock worth $7,177,000 after acquiring an additional 133,715 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its stake in shares of Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after acquiring an additional 1,062 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $346,000.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on GRDN shares. Truist Financial raised their price objective on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a research note on Thursday, March 12th. Weiss Ratings reissued a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. Raymond James Financial reissued an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research note on Thursday, March 12th. Zacks Research upgraded shares of Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 18th. Finally, Oppenheimer lifted their price objective on Guardian Pharmacy Services from $35.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Guardian Pharmacy Services presently has an average rating of “Buy” and a consensus target price of $38.00.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.